Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery

Following its therapeutic effect in hematological metastasis, chimeric antigen receptor (CAR) T cell therapy has gained a great deal of attention during the last years. However, the effectiveness of this treatment has been hampered by a number of challenges, including significant toxicities, difficu...

Descripción completa

Detalles Bibliográficos
Autores principales: Katopodi, Theodora, Petanidis, Savvas, Anestakis, Doxakis, Charalampidis, Charalampos, Chatziprodromidou, Ioanna, Floros, George, Eskitzis, Panagiotis, Zarogoulidis, Paul, Koulouris, Charilaos, Sevva, Christina, Papadopoulos, Konstantinos, Dagher, Marios, Varsamis, Nikolaos, Theodorou, Vasiliki, Mystakidou, Chrysi Maria, Katsios, Nikolaos Iason, Farmakis, Konstantinos, Kosmidis, Christoforos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610474/
https://www.ncbi.nlm.nih.gov/pubmed/37896218
http://dx.doi.org/10.3390/pharmaceutics15102458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610474/
https://www.ncbi.nlm.nih.gov/pubmed/37896218
http://dx.doi.org/10.3390/pharmaceutics15102458

Ejemplares similares